logoTry Persana

Sanguine Biosciences - Company Overview, Founder, CEO, Funding & Investment Details

Complete information about Sanguine Biosciences including founder details, CEO information, total funding raised, headquarters location, team size, and recent investment rounds.

Sanguine Biosciences company logo

Bridging the gap between researchers and patients

Sanguine Biosciences is accelerating personalized medicine by empowering patients with their healthcare data and facilitating participation in biomedical research.

HeadquartersWoburn, Massachusetts, United States
Team size101-250
Founded2010

What is Sanguine Biosciences? - Company Overview & Details

Sanguine Biosciences is Sanguine Biosciences is accelerating personalized medicine by empowering patients with their healthcare data and facilitating participation in biomedical research. Founded in 2010, the company is headquartered in Woburn, Massachusetts, United States.

Who Founded Sanguine Biosciences?

Sanguine Biosciences was founded by Brian Neman.

Who are the Key Executives at Sanguine Biosciences? - Leadership Team

Sanguine Biosciences is led by experienced executives in key positions:

Chief Executive Officer (CEO) of Sanguine Biosciences

Brian NemanCEO

About Brian Neman - CEO of Sanguine Biosciences

Brian Neman serves as the Chief Executive Officer of Sanguine Biosciences, leading the company's strategic vision and operations. Connect with them on LinkedIn for professional insights.

Sanguine Biosciences Company Details & Key Information

Where is Sanguine Biosciences located?

Sanguine Biosciences is headquartered in Woburn, Massachusetts, United States.

How many employees does Sanguine Biosciences have?

Sanguine Biosciences has 101-250 employees.

When was Sanguine Biosciences founded?

Sanguine Biosciences was founded in 2010.

Sanguine Biosciences Official Website

How much funding has Sanguine Biosciences raised?

Sanguine Biosciences has raised $10 Million across 9 funding rounds. The most recent funding was completed on 2023-10-30.

Funding Overview

Sanguine Biosciences secured $10 million in credit financing to support its growth and the development of apheresis-derived products.

$10 Million
Total Funding Raised
9
Funding Rounds
2023-10-30
Latest Round

Sanguine Biosciences Funding History

Debt financing
2023-10-30
$10 Million
Debt financing
2023-12-01
$6 Million

Who are the key investors in Sanguine Biosciences?

Sanguine Biosciences is backed by 1 key investors including Catalio Capital Management. These investors focus on Healthcare, Life Sciences sectors.

Sanguine Biosciences Investor Overview

1
Key Investors
2
Focus Areas
0
Notable Investments

Complete List of Sanguine Biosciences Investors

Catalio Capital Management

A leading multi-strategy healthcare and life science investment firm.

Investment Focus
Healthcare
Life Sciences

What sectors do Sanguine Biosciences investors focus on?

The investors backing Sanguine Biosciences primarily focus on Healthcare, Life Sciences sectors.

Healthcare
Life Sciences

Featured Investor: Catalio Capital Management

Catalio Capital Management

A leading multi-strategy healthcare and life science investment firm.

Notable Investments:

What are Sanguine Biosciences's future plans?

Sanguine Biosciences Sanguine aims to continue developing its apheresis and laboratory services to enhance personalized medicine research.

Sanguine Biosciences Strategic Outlook

Strategic Focus
Defined
2
Key Challenges
2
Growth Opportunities

What challenges does Sanguine Biosciences face?

Sanguine Biosciences has identified 2 key challenges that need to be addressed for continued growth and success.

Key Challenges for Sanguine Biosciences

1

Increasing competition in the biospecimen procurement market

2

Maintaining growth while ensuring quality

What opportunities does Sanguine Biosciences have?

Sanguine Biosciences has identified 2 key opportunities for growth and market expansion.

Growth Opportunities for Sanguine Biosciences

1

Expanding partnerships with biopharmaceutical companies

2

Enhancing technology for better data integration

Sanguine Biosciences Strategic Position Summary

Key Focus Areas

Sanguine Biosciences is addressing 2 strategic challenges to strengthen its market position.

Growth Potential

The company has identified 2 key opportunities for expansion and growth.

What are the latest news about Sanguine Biosciences?

Sanguine Biosciences has 2 recent news updates covering key business developments and market activities.

Sanguine Biosciences News Overview

2
Recent Articles
Active
Media Coverage
2023-10-30
Latest Update

What is Sanguine Biosciences in the news for?

Sanguine Biosciences is currently featured in news for Sanguinebio receives financing of $10M in credit financing. and other significant business developments.

Recent News Articles About Sanguine Biosciences

Article 1
2023-10-30

Sanguinebio receives financing of $10M in credit financing.

Sanguine Biosciences announces $10 million credit financing from Catalio Capital Management to fund continued growth.

yahoo.com
Read News
Article 2
2024-01-07

Sanguinebio recognized as "Great Places to Work" company.

For the past four years, Sanguine has received the prestigious designation as a "Great Places to Work" company.

prnewswire.com
Read News

Sanguine Biosciences FAQ - Frequently Asked Questions About Founder, CEO, Funding & Company Details

Find answers to the most common questions about Sanguine Biosciences including information about founders, CEO, funding history, investors, headquarters location, and company details. 18 frequently asked questions covering key information about the company.

Sanguine Biosciences Questions & Answers - Company Information

Q1

What is Sanguine Biosciences?

Sanguine Biosciences is accelerating personalized medicine by empowering patients with their healthcare data and facilitating participation in biomedical research.

Q2

Who founded Sanguine Biosciences?

Sanguine Biosciences was founded by Brian Neman.

Q3

Who is the CEO of Sanguine Biosciences?

The CEO of Sanguine Biosciences is Brian Neman. You can find more information about them on their LinkedIn profile.

Q4

How much funding has Sanguine Biosciences raised?

Sanguine Biosciences has raised a total of $$10 Million across 9 funding rounds. The most recent funding was completed on 2023-10-30.

Q5

Who are the investors in Sanguine Biosciences?

Sanguine Biosciences's key investors include Catalio Capital Management.

Q6

Where is Sanguine Biosciences headquartered?

Sanguine Biosciences is headquartered in Woburn, Massachusetts, United States.

Q7

When was Sanguine Biosciences founded?

Sanguine Biosciences was founded in 2010.

Q8

How many employees does Sanguine Biosciences have?

Sanguine Biosciences has 101-250 employees.

Q9

What is Sanguine Biosciences's official website?

You can visit Sanguine Biosciences's official website at https://www.sanguinebio.com.

Q10

What was Sanguine Biosciences's latest funding round?

Sanguine Biosciences's latest funding round was a Debt financing round of $$10 Million completed on 2023-10-30.

Q11

Who is founder?

Brian Neman

Q12

What does the company do?

Sanguine Biosciences accelerates personalized medicine by empowering patients with their healthcare data and facilitating participation in biomedical research.

Q13

How much funding?

$10 Million

Q14

Latest funding date?

2023-10-30

Q15

Who are the investors?

Catalio Capital Management

Q16

What are the challenges?

Increasing competition in the biospecimen procurement market Maintaining growth while ensuring quality

Q17

What are the opportunities?

Expanding partnerships with biopharmaceutical companies Enhancing technology for better data integration

Q18

Latest news?

Sanguine Biosciences announces $10 million credit financing from Catalio Capital Management to fund continued growth. For the past four years, Sanguine has received the prestigious designation as a "Great Places to Work" company.

More Information About Sanguine Biosciences

For additional details about Sanguine Biosciences, including the latest news, funding updates, and company developments, explore our comprehensive company database. Find information about startup funding, company valuations, executive leadership, and business intelligence data.